Welcome
The 2025 PSMA and Beyond Conference included presentations and discussions on:
- PSMA PET Imaging: We will delve into the intricacies of interpreting and reporting PSMA PET imaging, along with an evaluation of the current data supporting its use and its implications for patient care.
- PSMA-Targeted Radioligand Therapy: Gain insights into patient selection criteria and the optimal management of PSMA-targeted radioligand therapy.
- Combination Therapy and Future Trials: A critical review of the roles of combination therapy, the potential impact of ongoing and upcoming clinical trials, and the importance of dosimetry.
- Tumor Boards: Our sessions will utilize tumor boards to spotlight the pivotal role of PSMA imaging and therapy in the context of prostate cancer patients.
